Intens. Figure S3 . UV-vis (DAD) spectra of compound 1 (3.55 min) and secondary compound 1' (3.90 min) in peak 1. Figure S4 .
1 H NMR spectrum of peak 1 (DMSO-d 6 , 500 MHz). Figure S5 . HSQC spectrum of peak 1. Figure S6 . Key HMBC correlations for main compound 1 in peak 1, which connect theacetylcysteine moiety to the thiazoline heterocycle Figure S10. HRMS spectra of compound 2 (3.57 min) and secondary compound 2' (3.90 min) in peak 2. Intens. 400 500 600 700 800 900 m/z Figure S11 . UV-vis (DAD) spectra of compound 2 (3.57 min) and secondary compound 2' (3.91 min) in peak 2. Figure S12 . 1 H NMR spectrum of peak 2 (DMSO-d 6 , 500 MHz). Figure S13. HSQC spectrum of peak 2.
Structural characterization of compounds in peak 3
Figure S14. Chromatogram (trace at 210 nm) of peak 3. Figure S15 . HRMS spectra of compound 3 (3.77 min) and secondary compound 3' (4.07 min) in peak 3. Time (min) Figure S27 . UPLC chromatograms, monitored at 238 nm, of mutant S. albus B29 grown in R5A liquid medium and fed with 50 µg mL −1 of paulomycin B (6) that is transformed into paulomenol B (8) and compound (2). Figure S28 . UPLC chromatograms, monitored at 238 nm, of mutant S. albus B29 grown in R5A liquid medium and fed with 50 µg mL −1 of paulomycin A (5) that is transformed into paulomenol A (7) and compound (3).
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